BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
5.20
-0.83 (-13.76%)
At close: Apr 25, 2025, 4:00 PM
5.07
-0.13 (-2.50%)
After-hours: Apr 25, 2025, 6:12 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $22.57 million as of April 25, 2025. Its market cap has decreased by -50.39% in one year.
Market Cap
22.57M
Enterprise Value
16.95M
1-Year Change
-50.39%
Ranking
Category
Stock Price
$5.20
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $22.57M, a decrease of -13.19%. That is a compound annual growth rate of -3.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 22.40M | -10.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 779.45B |
| UnitedHealth Group | 376.51B |
| Johnson & Johnson | 370.35B |
| AbbVie | 323.97B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.32B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |